Expansion Award Program
Funding Amount
$50,000
Deadline
Deadline not published
Grant Type
Foundation
Deadline history & next window
- Cycle
- Annual
- Tracked since
- May 2026
Source: the cycle recorded on this listing. Confirm dates with the funder.
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Other requirements
- PI Requirements: Principal Investigator(s) must hold doctoral degrees
- Funding Status: PIs must be listed as PI on a single ventricle- or cardiovascular development-related grant funded through December 31, 2022
- Project Relevance: Proposed expansion plans must have demonstrated relevance to single ventricle heart disease or its associated sequelae
Overview
The Expansion Awards enable 'piggyback' funding for teams to add new directions or approaches to their currently funded work. This one-time grant supports researchers by expanding the scope of an existing project, expediting time to completion, or otherwise increasing the scientific interest or impact of existing studies already underway.
Award Details
- Award Amount: $50,000 (one-time grant)
- Award Duration: 12 months
- Recurrence: Annual
- Investment Impact: Supports next-generation equipment and technology housed in single ventricle research labs
Focus Areas
Proposals must include at least one of the following:
- Expansion of existing funded studies within the single ventricle research community; OR
- Addition of single-ventricle-directed aims to ongoing studies within the cardiovascular development field
Eligibility
- PI Requirements: Principal Investigator(s) must hold doctoral degrees
- Funding Status: PIs must be listed as PI on a single ventricle- or cardiovascular development-related grant funded through December 31, 2022
- Project Relevance: Proposed expansion plans must have demonstrated relevance to single ventricle heart disease or its associated sequelae
Application Scope
Proposals may showcase:
- Microscopy techniques
- Computational approaches
- Molecular techniques
- Validation of new sequencing approaches
- Movement from in vitro models to proof-of-concept in human tissue
- Pharmacological treatment development
- Project acceleration
Previous Cycles
- 2022 Expansion Award Recipients: 10 research teams selected, $490K+ investment
- Teams from institutions including Cornell University, Boston Children's Hospital, Children's Hospital of Philadelphia, University of Texas Medical Branch, Seattle Children's Hospital, University of California San Diego, Massachusetts General Hospital, University of Oxford, Medical College of Wisconsin, and Texas Children's Hospital
How to Apply
Application Process
- Submit Proposal - Complete proposal submission
- 2022 cycle deadline: May 2, 2022
- Subsequent cycles: Check website for updated deadlines
- Proposal Review - Applications reviewed for scientific merit and expansion impact
- Selection and Notification - Successful proposals notified and funded
Required Materials
- Proposal describing expansion of existing funded work
- Description of how expansion adds new directions or approaches
- Documentation of current funding status (PI listed on active grant)
- Demonstration of relevance to single ventricle disease or sequelae
Proposal Considerations
- How expansion will increase scientific interest or impact
- Timeline and feasibility of 12-month project
- Relevance to single ventricle research community
- Ability to move research forward (e.g., from in vitro to human tissue testing)
Past recipients of this program
Recent awards under this program (from Additional Ventures Foundation's IRS filings)
The Board of Trustees of the Leland Stanford Junior University
Redwood City, CA · 2023
$50K
New Haven, CT · 2023
$50K
Houston, TX · 2023
$50K
The J David Gladstone Institutes
San Francisco, CA · 2023
$50K
University of Southern California
Los Angeles, CA · 2023
$50K
33 grants in Additional Ventures Foundation's 2021–2023 filings reference “Expansion Award Program” in their stated purpose. Amounts and places as reported by the funder.
What Additional Ventures Foundation actually gave
Source: IRS Form 990-PF, 2024
- Grants in 2024
- 68
- Total given
- $17.15M
- Median grant
- $220K
- Range
- $2,500–$1.2M
- By dollars: California 30%, Massachusetts 9%, Pennsylvania 9%. Top recipient cities: Boston, MA; Redwood City, CA; New York, NY.
- 0% of grants with a stated purpose were for general or operating support.
Example grants
The J David Gladstone Institutes · San Francisco, CA
Innovation award
$1.2M
Renata Medical Inc · Newport Beach, CA
Transcatheter fontan shunt development
$1.1M
Boston Children's Hospital · Boston, MA
Force fund
$934K
Nationwide Children's Hospital Inc · Columbus, OH
Cures collaborative
$595K
Carnegie Mellon University · Pittsburgh, PA
Cures collaborative
$493K
Focus Areas & Funding Uses
Fields of Work
- Science research
- Heart disease
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Expansion Award Grant
Additional Ventures Foundation
Amount
Up to US $50,000
Deadline
Deadline not published
Single Ventricle Research Fund (SVRF)
Additional Ventures Foundation
Amount
Up to $600,000
Deadline
Deadline not published
Single Ventricle Research Fund (SVRF) Grant
Additional Ventures Foundation
Amount
Up to US $600,000
Deadline
Deadline not published
Outstanding Research Presentation Award
Additional Ventures Foundation
Amount
Varies
Deadline
Deadline not published
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
National Institutes of Health
Amount
Up to $1,515,000
Deadline
January 7, 2027
Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
National Institutes of Health
Amount
$4,500,000 total
Deadline
March 10, 2027
Ready to apply for Expansion Award Program?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Expansion Award Program. Now let's win it.